Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 31-Jul-20 4:54 PM View:  | Nabriva Therapeutics Plc (NBRV) | 29-Jul-20 | Grant | 17,500 | -- | -- | 37% 47.64K to 65.14K | |
| 02-Aug-18 5:52 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Jul-18 | Market Purchase | 14,500 | $2.75 | $39,875.00 | 44% 33.14K to 47.64K | (90%) |
| 29-Sep-17 7:34 PM View: | Nabriva Therapeutics Plc (NBRV) | 27-Sep-17 | Option Exercise | 1,350 | -- | -- | 4% 31.79K to 33.14K | |
| 27-Jun-17 9:54 PM View: | Nabriva Therapeutics Legacy... (NBRV) | 23-Jun-17 | Acquisition (other) | 31,790 | -- | -- | 100% 0 to 31.79K | |
| 19-Jun-17 6:14 PM View: | Nabriva Therapeutics Plc (NBRV) | 19-Jun-17 | Private Sale | 46 | $91.00 | $4,186.00 | (1%) 3.23K to 3.18K | |
| 19-Jun-17 6:14 PM View: | Nabriva Therapeutics Plc (NBRV) | 16-Jun-17 | Private Sale | 24 | $93.50 | $2,244.00 | (< 1%) 3.25K to 3.23K | |
| 19-Jun-17 6:14 PM View: | Nabriva Therapeutics Plc (NBRV) | 15-Jun-17 | Private Sale | 100 | $94.10 | $9,410.00 | (3%) 3.35K to 3.25K | |
| 01-Jun-17 8:49 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-May-17 | Private Sale | 210 | $101.26 | $21,265.00 | (6%) 3.56K to 3.35K | |
| 25-May-17 8:58 PM View: | Nabriva Therapeutics Plc (NBRV) | 25-May-17 | Private Sale | 295 | $100.65 | $29,692.50 | (8%) 3.85K to 3.56K | |
| 25-May-17 8:58 PM View: | Nabriva Therapeutics Plc (NBRV) | 23-May-17 | Private Sale | 30 | $99.70 | $2,991.00 | (< 1%) 3.88K to 3.85K | |
| 17-May-17 7:01 PM View: | Nabriva Therapeutics Plc (NBRV) | 16-May-17 | Private Option Sale | 150 | $102.76 | $15,413.40 | (4%) 4.03K to 3.88K | |
| 17-May-17 7:01 PM View: | Nabriva Therapeutics Plc (NBRV) | 15-May-17 | Private Option Sale | 50 | $101.50 | $5,075.00 | (1%) 4.08K to 4.03K | |
| 17-May-17 7:01 PM View: | Nabriva Therapeutics Plc (NBRV) | 16-Feb-17 | Option Exercise | 1,235 | -- | -- | 43% 2.85K to 4.08K |